| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $74K | — | +0.0% |
| R&D Expense | $1.1M | — | -61.3% |
| SG&A Expense | $5.7M | — | +65.3% |
| Operating Income | -$6.8M | — | -8.6% |
| Pre-tax Income | -$6.4M | — | -18.2% |
| Net Income | -$6.4M | — | -18.2% |
| EPS (Basic) | -$0.02 | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $73.3M | +387.3% | +1920.4% |
| Current Assets | $78.3M | +292.2% | +414.8% |
| Total Assets | $78.7M | +285.0% | +390.5% |
| Current Liabilities | $1.6M | -76.4% | -82.1% |
| Total Liabilities | $1.7M | -75.7% | -81.9% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.2M | — | -317.8% |
| Capital Expenditures | $2K | — | — |
| Investing Cash Flow | -$42K | — | — |
| Financing Cash Flow | $67.2M | — | — |
| Free Cash Flow | -$9.2M | — | — |
| +93.1% |
| EPS (Diluted) | -$0.02 | — | +93.1% |
| $77.0M |
| +475.2% |
| +1067.7% |